SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Segment Reporting [Line Items] | ||||||
| Net revenue | $ 31,880,000 | $ 27,377,000 | $ 63,150,000 | $ 55,009,000 | ||
| Direct operating costs | 17,457,000 | 14,480,000 | 34,307,000 | 29,944,000 | ||
| Selling and marketing | 1,300,000 | 1,118,000 | 2,714,000 | 2,249,000 | ||
| General and administrative | 5,370,000 | 4,358,000 | 10,866,000 | 8,690,000 | ||
| Research and development | 2,194,000 | 1,020,000 | 4,610,000 | 2,255,000 | ||
| Change in contingent consideration | (34,000) | 23,000 | ||||
| Depreciation and amortization | 3,731,000 | 3,382,000 | 7,768,000 | 6,719,000 | ||
| Restructuring costs | 23,000 | 137,000 | ||||
| Total operating expenses | 30,018,000 | 24,381,000 | 60,288,000 | 49,994,000 | ||
| OPERATING INCOME | 1,862,000 | 2,996,000 | 2,862,000 | 5,015,000 | ||
| Unallocated corporate expenses | (2,103,000) | (1,446,000) | (4,283,000) | (3,024,000) | ||
| Net interest expense | (742,000) | (17,000) | (790,000) | (33,000) | ||
| Other income (expense) - net | 104,000 | (35,000) | 126,000 | (49,000) | ||
| INCOME BEFORE PROVISION FOR INCOME TAXES | 1,224,000 | 2,944,000 | 2,198,000 | 4,933,000 | ||
| Operating Segments [Member] | ||||||
| Segment Reporting [Line Items] | ||||||
| Net revenue | 31,880,000 | 27,377,000 | 63,150,000 | 55,009,000 | ||
| Direct operating costs | 17,457,000 | 14,480,000 | 34,307,000 | 29,944,000 | ||
| Selling and marketing | 1,300,000 | 1,118,000 | 2,714,000 | 2,249,000 | ||
| General and administrative | 3,267,000 | 2,912,000 | 6,583,000 | 5,666,000 | ||
| Research and development | 2,194,000 | 1,020,000 | 4,610,000 | 2,255,000 | ||
| Change in contingent consideration | (34,000) | 23,000 | ||||
| Depreciation and amortization | 3,731,000 | 3,382,000 | 7,768,000 | 6,719,000 | ||
| Restructuring costs | 23,000 | 137,000 | ||||
| Total operating expenses | 27,915,000 | 22,935,000 | 56,005,000 | 46,970,000 | ||
| OPERATING INCOME | 3,965,000 | 4,442,000 | 7,145,000 | 8,039,000 | ||
| Healthcare IT [Member] | Operating Segments [Member] | ||||||
| Segment Reporting [Line Items] | ||||||
| Net revenue | 28,194,000 | 24,077,000 | 55,698,000 | 48,719,000 | ||
| Direct operating costs | 14,436,000 | 11,763,000 | 28,259,000 | 24,666,000 | ||
| Selling and marketing | 1,298,000 | 1,110,000 | 2,704,000 | 2,234,000 | ||
| General and administrative | 2,550,000 | 2,343,000 | 5,223,000 | 4,455,000 | ||
| Research and development | 2,194,000 | 1,020,000 | 4,610,000 | 2,255,000 | ||
| Change in contingent consideration | (34,000) | 23,000 | ||||
| Depreciation and amortization | 3,648,000 | 3,300,000 | 7,603,000 | 6,555,000 | ||
| Restructuring costs | 23,000 | 137,000 | ||||
| Total operating expenses | 24,092,000 | 19,559,000 | 48,422,000 | 40,302,000 | ||
| OPERATING INCOME | 4,102,000 | 4,518,000 | 7,276,000 | 8,417,000 | ||
| Medical Practice Management [Member] | ||||||
| Segment Reporting [Line Items] | ||||||
| Net revenue | 3,686,000 | 3,300,000 | 7,452,000 | 6,290,000 | ||
| Medical Practice Management [Member] | Operating Segments [Member] | ||||||
| Segment Reporting [Line Items] | ||||||
| Net revenue | [1] | 3,686,000 | 3,300,000 | 7,452,000 | 6,290,000 | |
| Direct operating costs | 3,021,000 | 2,717,000 | 6,048,000 | 5,278,000 | ||
| Selling and marketing | 2,000 | 8,000 | 10,000 | 15,000 | ||
| General and administrative | 717,000 | 569,000 | 1,360,000 | 1,211,000 | ||
| Research and development | ||||||
| Change in contingent consideration | ||||||
| Depreciation and amortization | 83,000 | 82,000 | 165,000 | 164,000 | ||
| Restructuring costs | ||||||
| Total operating expenses | 3,823,000 | 3,376,000 | 7,583,000 | 6,668,000 | ||
| OPERATING INCOME | $ (137,000) | $ (76,000) | $ (131,000) | $ (378,000) | ||
| ||||||
| X | ||||||||||
- Definition Unallocated corporate expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|